Antimicrobial activity of Fosfomycin and Tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions
Antimicrobial therapy has been a major contributor to the increased life expectancy of CF patients since CF was first describe<! in 1938. However, the high antimicrobial consumption in this patient population means that resistance has become a major problem in CF. As such, there is a need for new...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.602403 |